China Ovarian Cancer BRCA Testing Study

Trial Identifier: D133FR00117
Sponsor: AstraZeneca
NCTID:: NCT03203993
Start Date: January 2018
Primary Completion Date: March 2020
Study Completion Date: March 2020
Condition: Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China, Anhui Hefei, Anhui, China, 230601
China, Beijing Beijing, China, 100730
China, Beijing Beijing, China, 100191
China, Beijing Beijing, China, 100142
China, Chongqing Chongqing, China, 400030
China, Guangdong Guangzhou, Guangdong, China, 510220
China, Guangdong Guangzhou, Guangdong, China, 510060
China, Guangdong Guangzhou, Guangdong, China, 510080
China, Henan Zhengzhou, Henan, China, 450008
China, Hubei Wuhan, Hubei, China, 430030
China, Hunan Changsha, Hunan, China, 410000
China, Shandong Jinan, Shandong, China, 250014
China, Shanghai Shanghai, China, 200032
China, Shanghai Shanghai, China, 200080
China, Sichuan Chengdu, Sichuan, China, 610041
China, Tianjin Tianjin, China, 300110
China, Tianjin Tianjin, China, 300202
China, Zhejiang Hangzhou, Zhejiang, China, 310006
Hong Kong Hong Kong, Hong Kong, 0